← Back to Clinical Trials
Recruiting NCT07424066

NCT07424066 Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performance

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07424066
Status Recruiting
Phase
Sponsor University of Milano Bicocca
Condition Vibration
Study Type INTERVENTIONAL
Enrollment 35 participants
Start Date 2025-05-20
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Vibratory stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 35 participants in total. It began in 2025-05-20 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this interventional cross-sectional study is to evaluate motor responses to non-invasive vibratory stimulation applied to the hamstring muscle tendons in healthy individuals. Knee flexion and extension efforts, in both isometric and concentric contractions, will be tested. The investigators hypothesize that vibratory stimulation causes an increase in activity in the flexor muscles (hamstrings) and a decrease in the extensor muscles (quadriceps) of the knee in all motor tasks. It follows that during knee flexion (both concentric and isometric), vibratory stimulation should cause an increase in the distance between the angular trajectories of the knee obtained with and without vibratory stimulation (with a positive sign). The increased activity of the hamstring muscles would, in fact, contribute to increasing the velocity of the flexor movement. Conversely, during extensor movements (both concentric and isometric), vibratory stimulation should reduce the instantaneous velocity of the movement, therefore causing an increase in distance (with a negative sign) between the trajectories obtained with and without stimulation. Participants will be tested using an isokinetic dynamometer and they will be asked to perform the following motor tasks in a random order: concentric knee flexion, concentric knee extension, isometric knee flexion, and isometric knee extension. The dominant limb will be tested, only. The assessment will be performed one time.

Eligibility Criteria

Inclusion Criteria: * Age equal to or greater than 18 years. Exclusion Criteria: * Neurological disorders. * Musculoskeletal injuries, including previous ones, that may compromise the execution of required movements. * Cardiorespiratory disorders.

Contact & Investigator

Central Contact

Stefano Scarano, Medical Doctor

✉ s.scarano@auxologico.it

📞 +3902619116717

Principal Investigator

Cristiano Alessandro, Engineering

PRINCIPAL INVESTIGATOR

University of Milano Bicocca

Frequently Asked Questions

Who can join the NCT07424066 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Vibration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07424066 currently recruiting?

Yes, NCT07424066 is actively recruiting participants. Contact the research team at s.scarano@auxologico.it for enrollment information.

Where is the NCT07424066 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT07424066 clinical trial?

NCT07424066 is sponsored by University of Milano Bicocca. The principal investigator is Cristiano Alessandro, Engineering at University of Milano Bicocca. The trial plans to enroll 35 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology